BARCLAYS PLC

Position in NVCT — Nuvectis Pharma, Inc.

CIK 312069 LONDON, X0

Position in NVCT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$24,124

-$158,472 QoQ

Shares Held

3,121

-87.1% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. NVCT ranks #305 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	663,263	$296,173,457
2	REGN	Regeneron Pharmaceuticals, Inc.	313,093	$241,908,173
3	ALNY	Alnylam Pharmaceuticals, Inc.	220,623	$72,997,531
4	MRNA	Moderna, Inc.	932,269	$47,359,264
5	INSM	INSMED Inc	275,731	$45,087,531
6	ROIV	Roivant Sciences Ltd.	1,415,848	$39,218,988
7	RVMD	Revolution Medicines, Inc.	383,179	$37,264,156
8	TERN	Terns Pharmaceuticals, Inc.	669,601	$35,301,364

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$24,124	3,121	-87.1%	Shares	Defined	2026-05-15
2025-12-31	$182,596	24,185	+31.3%	Shares	Sole	2026-02-13
2025-09-30	$110,918	18,425	-20.5%	Shares	Sole	2026-03-31
2025-06-30	$173,109	23,174	+1899.5%	Shares	Sole	2026-02-27
2025-03-31	$11,322	1,159	+1.3%	Shares	Sole	2026-03-17
2024-12-31	$6,189	1,144	0.0%	Shares	Sole	2026-03-19
2024-09-30	$7,195	1,144	-86.2%	Shares	Sole	2026-03-31
2024-06-30	$52,349	8,270	-19.7%	Shares	Sole	2026-03-23
2024-03-31	$84,402	10,293	+0.4%	Shares	Sole	2026-03-24
2023-12-31	$85,518	10,254	+638.2%	Shares	Sole	2026-03-24
2023-09-30	$17,904	1,389	+1.3%	Shares	Sole	2026-03-26
2023-06-30	$21,894	1,371	—	Shares	Sole	2026-03-27
No filing history on record for this holder in this stock.